Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-27 @ 4:08 PM
Study NCT ID:
NCT02383368
Status:
COMPLETED
Last Update Posted:
2024-10-31
First Post:
2015-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-04
First Submit QC Date:
None
Study First Post Date:
2015-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-29
Last Update Post Date:
2024-10-31
Last Update Post Date Type:
ACTUAL